How to interpret phase II data for everolimus plus bevacizumab in renal cell carcinoma (Q43109180)
Jump to navigation
Jump to search
scientific article published on 5 April 2010
Language | Label | Description | Also known as |
---|---|---|---|
English | How to interpret phase II data for everolimus plus bevacizumab in renal cell carcinoma |
scientific article published on 5 April 2010 |
Statements
1 reference
How to interpret phase II data for everolimus plus bevacizumab in renal cell carcinoma (English)
1 reference
Bernard Escudier
1 reference
5 April 2010
1 reference
1 reference
28
1 reference
13
1 reference
2125-2126
1 reference
Identifiers
1 reference
1 reference